Salvo Health
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
* | $10.5m | Seed | |
* | $5.0m Valuation: $52.5m | Seed | |
Total Funding | €14.1m |
Recent News about Salvo Health
EditSalvo Health is a healthcare startup focused on revolutionizing the treatment of metabolic liver diseases, particularly fatty liver disease. The company operates in the digital health market, providing personalized care through cutting-edge technology. Salvo Health primarily serves patients suffering from chronic liver and gut issues, offering them a more efficient and responsive healthcare experience.
The core of Salvo Health's business model is its Remote Patient Monitoring (RPM) system for Metabolic Associated Steatohepatitis (MASH) and Metabolic Associated Steatotic Liver Disease (MASLD). This system allows patients to communicate with their care team via text, enabling real-time health management without the need for frequent in-person doctor visits. This approach not only improves patient outcomes but also enhances patient satisfaction by offering a more convenient and responsive healthcare solution.
Salvo Health makes money through a subscription-based model, where patients pay a recurring fee for continuous access to their personalized care plans and the ability to communicate with their care team. Additionally, the company collaborates with healthcare payers and practices, potentially receiving reimbursements and partnership fees for its innovative care solutions.
In summary, Salvo Health is leveraging technology to provide a more personalized and efficient healthcare experience for patients with chronic liver and gut issues. By focusing on real-time communication and personalized care plans, the company aims to improve patient outcomes and satisfaction.
Keywords: Digital Health, Fatty Liver Disease, Personalized Care, Remote Monitoring, Subscription Model, Chronic Conditions, Real-time Communication, Patient Satisfaction, Healthcare Innovation, Metabolic Diseases.